Idiopathic Urticaria
📧 Sign up to get email alerts when something new happens for Idiopathic Urticaria.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-09-15FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (7-eleven)
FDA approved a supplemental application for fexofenadine hydrochloride (ANDA 202039) submitted by 7-eleven.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines [Phase 2]
Phase 2 trial evaluating the efficacy and safety of AZD1981, a CRTh2 antagonist, in chronic idiopathic urticaria; the study is completed and…
-
FDA approval · 2017-07-10FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc.
-
FDA approval · 2017-05-15FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved the original application for levocetirizine dihydrochloride (generic) from Chartwell RX, LLC.
-
FDA approval · 2017-02-09FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) from Chattem, Inc., approving changes to the product's la…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-01-31FDA Approved: XYZAL ALLERGY 24HR — Original Application (Chattem, Inc.)
FDA Approved: XYZAL ALLERGY 24HR (levocetirizine dihydrochloride) by Chattem, Inc. under an Original Application. The product is indicated f…
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for cetirizine hydrochloride from PAI Holdings, LLC dba PAI Pharma. This action approves a supplemen…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Efficacy Study of Canakinumab to Treat Urticaria [Phase 2]
Phase 2 clinical trial update evaluating canakinumab for chronic idiopathic urticaria; the current status of the study is unknown.
-
FDA approval · 2016-09-23FDA Approved: LORATADINE — Original Application (MARKSANS PHARMA LIMITED)
FDA approved loratadine via an Original Application (ANDA) for Marksans Pharma Limited, expanding access to a generic antihistamine.
-
FDA approval · 2016-08-19FDA Approved: FEXOFENADINE HCL — Original Application (Strategic Sourcing Services)
FDA approves the original application for fexofenadine hydrochloride, a generic antihistamine, submitted by Strategic Sourcing Services.
-
FDA label_change · 2016-08-09FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) submitted by Bayer HealthCare LLC, indicating a labeling change for the ma…
-
FDA label_change · 2016-06-23FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc., likely resulting in labeling …
-
FDA approval · 2016-06-16FDA Approved: CLARINEX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for CLARINEX (desloratadine) submitted by Organon LLC. The action confirms regulatory approval relat…
-
FDA approval · 2016-05-26FDA Approved: DESLORATADINE ORAL SOLUTION — Original Application (INA Pharmaceutics, Inc.)
INA Pharmaceutics' Desloratadine oral solution received FDA approval as a generic version of desloratadine for allergic rhinitis and chronic…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria [Phase 2]
This clinical trial update reports on a Phase 2 study of methotrexate for chronic idiopathic urticaria, which has been terminated.
-
FDA approval · 2016-01-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for levocetirizine dihydrochloride from Macleods Pharmaceuticals Limited as a generic antihistamine.
-
FDA approval · 2015-11-25FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Glenmark Pharmaceuticals' generic levocetirizine dihydrochloride.
-
FDA approval · 2015-11-24FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for levocetirizine dihydrochloride from Camber Pharmaceuticals, confirming its status as a generic a…
-
FDA approval · 2015-10-01FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals Inc)
FDA approved a supplemental application for levocetirizine dihydrochloride from Marlex Pharmaceuticals Inc, indicating an approved regulator…
-
FDA approval · 2015-09-24FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Chewable Grape and Bubblegum (loratadine) from Bayer HealthCare LLC, expanding the …
-
FDA approval · 2015-09-16FDA Approved: FEXOFENADINE HCL — Original Application (AKRON PHARMA INC)
FDA approved Akron Pharma Inc's original ANDA for fexofenadine hydrochloride (Fexofenadine HCl), a generic antihistamine for allergic rhinit…
-
FDA approval · 2015-07-31FDA Approved: LORATADINE — Original Application (WALGREEN COMPANY)
FDA approves Walgreens' original submission for Loratadine (ANDA 201865), granting generic approval for loratadine. Loratadine is an antihis…
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: Etanercept for the Treatment of Chronic Urticaria [Phase 2, Phase 3]
A Phase 2/3 clinical trial of etanercept for chronic idiopathic urticaria has been withdrawn.
-
FDA approval · 2015-02-25FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (AMERISOURCE BERGEN)
FDA approved a supplemental application for fexofenadine hydrochloride submitted by Amerisource Bergen, updating the regulatory status of th…
-
FDA approval · 2015-02-11FDA Approved: DESLORATADINE — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for desloratadine filed by Bionpharma Inc.